BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29163849)

  • 1. The therapeutic potential of cell cycle targeting in multiple myeloma.
    Maes A; Menu E; Veirman K; Maes K; Vand Erkerken K; De Bruyne E
    Oncotarget; 2017 Oct; 8(52):90501-90520. PubMed ID: 29163849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
    Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
    J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and others.
    Warner SL; Gray PJ; Von Hoff DD
    Semin Oncol; 2006 Aug; 33(4):436-48. PubMed ID: 16890798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome separation and exit from mitosis in budding yeast: dependence on growth revealed by cAMP-mediated inhibition.
    Anghileri P; Branduardi P; Sternieri F; Monti P; Visintin R; Bevilacqua A; Alberghina L; Martegani E; Baroni MD
    Exp Cell Res; 1999 Aug; 250(2):510-23. PubMed ID: 10413604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of anaphase-promoting complex genes in human colon cancer cells.
    Wang Q; Moyret-Lalle C; Couzon F; Surbiguet-Clippe C; Saurin JC; Lorca T; Navarro C; Puisieux A
    Oncogene; 2003 Mar; 22(10):1486-90. PubMed ID: 12629511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1.
    van de Weerdt BC; van Vugt MA; Lindon C; Kauw JJ; Rozendaal MJ; Klompmaker R; Wolthuis RM; Medema RH
    Mol Cell Biol; 2005 Mar; 25(5):2031-44. PubMed ID: 15713655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1.
    Eldridge AG; Loktev AV; Hansen DV; Verschuren EW; Reimann JD; Jackson PK
    Cell; 2006 Jan; 124(2):367-80. PubMed ID: 16439210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A roller coaster ride with the mitotic cyclins.
    Fung TK; Poon RY
    Semin Cell Dev Biol; 2005 Jun; 16(3):335-42. PubMed ID: 15840442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis.
    Eckerdt F; Strebhardt K
    Cancer Res; 2006 Jul; 66(14):6895-8. PubMed ID: 16849530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe.
    Cives M; Ciavarella S; Rizzo FM; De Matteo M; Dammacco F; Silvestris F
    Cell Signal; 2013 May; 25(5):1108-17. PubMed ID: 23380051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pure antiestrogen-induced G1-arrest in myeloma cells results from the reduced kinase activity of cyclin D3/CDK6 complexes whereas apoptosis is mediated by endoplasmic reticulum-dependent caspases.
    Gauduchon J; Seguin A; Marsaud V; Clay D; Renoir JM; Sola B
    Int J Cancer; 2008 May; 122(9):2130-41. PubMed ID: 18183592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
    Lub S; Maes A; Maes K; De Veirman K; De Bruyne E; Menu E; Fostier K; Kassambara A; Moreaux J; Hose D; Leleu X; King RW; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2016 Jan; 7(4):4062-76. PubMed ID: 26716651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destruction box-dependent degradation of aurora B is mediated by the anaphase-promoting complex/cyclosome and Cdh1.
    Stewart S; Fang G
    Cancer Res; 2005 Oct; 65(19):8730-5. PubMed ID: 16204042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
    Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
    J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Suc1 in the activation of the cyclosome by protein kinase Cdk1/cyclin B.
    Shteinberg M; Hershko A
    Biochem Biophys Res Commun; 1999 Apr; 257(1):12-8. PubMed ID: 10092502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
    Sørensen CS; Lukas C; Kramer ER; Peters JM; Bartek J; Lukas J
    Mol Cell Biol; 2001 Jun; 21(11):3692-703. PubMed ID: 11340163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of metaphase-anaphase progression by proteolysis: cyclosome function regulated by the protein kinase A pathway, ubiquitination and localization.
    Yanagida M; Yamashita YM; Tatebe H; Ishii K; Kumada K; Nakaseko Y
    Philos Trans R Soc Lond B Biol Sci; 1999 Sep; 354(1389):1559-69; discussion 1569-70. PubMed ID: 10582241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells.
    Medina-Aguilar R; Marchat LA; Arechaga Ocampo E; Gariglio P; García Mena J; Villegas Sepúlveda N; Martínez Castillo M; López-Camarillo C
    Oncol Rep; 2016 Jun; 35(6):3696-704. PubMed ID: 27109433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Wait anaphase" signals are not confined to the mitotic spindle.
    Heasley LR; Markus SM; DeLuca JG
    Mol Biol Cell; 2017 May; 28(9):1186-1194. PubMed ID: 28298492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.